BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//LifeSci Events - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LifeSci Events
X-ORIGINAL-URL:https://lifescievents.com
X-WR-CALDESC:Events for LifeSci Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260617T100000
DTEND;TZID=America/New_York:20260617T113000
DTSTAMP:20260529T102815
CREATED:20260504T215512Z
LAST-MODIFIED:20260528T181933Z
UID:3038-1781690400-1781695800@lifescievents.com
SUMMARY:Saniona Virtual R&D Day: SAN2668 (GABAA PAM) for the Treatment of Severe Pediatric Epilepsies
DESCRIPTION:Join Saniona for a virtual R&D Day featuring key opinion leader (KOL) Nicola Specchio\, MD\, PhD (Bambino Gesù Children’s Hospital\, IRCCS\, Rome\, Italy)\, a globally recognized expert and principal investigator on multiple trials in pediatric epilepsy\, who will join company management to discuss the significant unmet need and current treatment landscape for severe pediatric epilepsies\, including Developmental Epileptic Encephalopathies (DEEs). These syndromes are often highly drug-resistant\, associated with substantial seizure burden and developmental impairment\, and can have lifelong consequences for patients and families. \nAs the first in a series of webinars designed to provide a focused overview of Saniona’s differentiated CNS pipeline\, this initial event will highlight SAN2668\, an oral\, selective GABAA positive allosteric modulator\, and will review the rationale for targeting GABAA\, key preclinical data supporting SAN2668\, the proposed Phase 1 clinical development path\, and the broader disease landscape and market opportunity. \nA live question and answer session will follow the formal presentations. Watch the webcast by clicking this link and logging in with the email address you used to register: https://lifescievents.com/event/g92rwe6y/.
URL:https://lifescievents.com/event/g92rwe6y/
LOCATION:Virtual\, Virtual
ATTACH;FMTTYPE=image/png:https://lifescievents.com/wp-content/uploads/2026/05/Saniona-Banner-2.png
END:VEVENT
END:VCALENDAR